A case of severe acalculous cholecystitis associated with sorafenib treatment for advanced hepatocellular carcinoma

Sorafenib, a multikinase inhibitor, is the first and only drug, which improves significantly the overall survival in patients with advanced hepatocellular carcinoma (HCC). However, many patients experience diverse side effects, some of them severe and unexpected. To date, acute acalculous cholecysti...

詳細記述

保存先:
書誌詳細
主要な著者: Aihara, Yosuke, Yoshiji, Hitoshi, Yamazaki, Masaharu, Ikenaka, Yasuhide, Noguchi, Ryuichi, Morioka, Chie, Kaji, Kosuke, Tastumi, Haruki, Nakanishi, Keisuke, Nakamura, Maiko, Yamao, Junichi, Toyohara, Masahisa, Mitoro, Akira, Sawai, Masayoshi, Yoshida, Motoyuki, Fujimoto, Masao, Uemura, Masahito, Fukui, Hiroshi
フォーマット: Artigo
言語:Inglês
出版事項: Baishideng Publishing Group Co., Limited 2012
主題:
Case Report
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3360105/
https://ncbi.nlm.nih.gov/pubmed/22645635
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4251/wjgo.v4.i5.115
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料